FindTrial
Sign In

Abrocitinib in the Treatment of Glucocorticoid-Refractory Acute Urticaria: A Case Series

Abrocitinib in the Treatment of Glucocorticoid-Refractory Acute Urticaria: A Case Series

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500098251
Enrollment
Unknown
Registered
2025-03-05
Start date
2025-03-05
Completion date
Unknown
Last updated
2025-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute urticaria

Interventions

treatment group:None

Sponsors

Zhejiang Provincial Tongde Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with acute urticaria uncontrolled with systemic glucocorticosteroids therapy , or relapse rapidly following treatment cessation

Exclusion criteria

Exclusion criteria: Adult patients with tuberculosis, tumor, hepatitis (active infection) or acute infection

Design outcomes

Primary

MeasureTime frame
urticaria activity score;—

Countries

China

Contacts

Public ContactDongmei Wang

Zhejiang Provincial Tongde Hospital

2277239451@qq.com+86 135 8819 9298

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026